INFLUENZA VIRUS-BASED ISOLATED RECOMBINANT VIRUS

The present invention relates to the fields of biotechnology, immunology, virology, genetics, and molecular biology. More specifically, the present invention relates to an isolated nucleic acid encoding a recombinant polypeptide for increasing the titer of antibodies to influenza virus (variants), a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: USTIUGOV, Iakov Iurevich, RUDENKO, Larisa Georgievna, ISAKOVA-SIVAK, Irina Nikolayevna, STEPANOVA, Ekaterina Alekseevna, DORONIN, Aleksandr Nikolaevich, NETEREBSKII, Bogdan Olegovich, IAKOVLEV, Pavel Andreevich, MATIUSHENKO, Viktoriia Arkadienva, MOROZOV, Dmitry Valentinovich, ALEKSANDROV, Aleksei Aleksandrovich, VLADIMIROVA, Anna Konstantinovna, NISKANEN, Sergei Andreevich, OSTROUKHOVA, Tatiana Urevna, SHEUDZHEN, Timur Mugdinovich
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to the fields of biotechnology, immunology, virology, genetics, and molecular biology. More specifically, the present invention relates to an isolated nucleic acid encoding a recombinant polypeptide for increasing the titer of antibodies to influenza virus (variants), an influenza virus-based recombinant virus for inducing specific immunity to influenza virus and/or preventing influenza virus-related diseases, a pharmaceutical composition and a vaccine that include the above influenza virus-based recombinant virus, as well as their use for inducing specific immunity to influenza virus and/or preventing influenza virus-related diseases.